Your browser doesn't support javascript.
loading
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed label.
Stefanovic, Sebastian; Detrez, Iris; Compernolle, Griet; Brouwers, Els; Sever, Nejc; Stabuc, Borut; Smrekar, Natasa; Kurent, Tina; Novak, Gregor; Kozelj, Matic; Ferrante, Marc; Gils, Ann; Drobne, David.
Afiliación
  • Stefanovic S; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Detrez I; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
  • Compernolle G; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
  • Brouwers E; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
  • Sever N; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Stabuc B; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Smrekar N; Medical Faculty, University of Ljubljana, Ljubljana, Slovenia.
  • Kurent T; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Novak G; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Kozelj M; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Ferrante M; Department of Gastroenterology and Hepatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
  • Gils A; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
  • Drobne D; Department of Pharmaceutical and Pharmacological Sciences, Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven, Leuven, Belgium.
Eur J Gastroenterol Hepatol ; 33(1): 54-61, 2021 01.
Article en En | MEDLINE | ID: mdl-32804854
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Eslovenia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colitis Ulcerosa Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Gastroenterol Hepatol Asunto de la revista: GASTROENTEROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Eslovenia Pais de publicación: Reino Unido